We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

70 hedge funds and large institutions have $155M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 7

53% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 15

32% more funds holding

Funds holding: 53 → 70 (+17)

19% less capital invested

Capital invested by funds: $193M → $155M (-$37.2M)

Holders
70
Holders Change
+17
Holders Change %
+32.08%
% of All Funds
1.95%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
24
Increased
23
Reduced
15
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$8.2M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.32M
3
O
OrbiMed
New York
+$3.84M
4
RCM
RA Capital Management
Massachusetts
+$3.41M
5
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
+$1.86M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$37.6M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$1.31M
3
BA
BlackRock Advisors
Delaware
-$880K
4
TAF
Tredje AP-fonden
Sweden
-$848K
5
AIC
AWM Investment Company
New York
-$812K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$823K +$6.62K +623 +0.8%
DCM
27
DAFNA Capital Management
California
$780K +$753K +70,885 New
NFA
28
Nationwide Fund Advisors
Ohio
$617K +$505K +47,525 +557%
FSA
29
Franklin Street Advisors
North Carolina
$551K +$531K +50,000 New
BIM
30
BlackRock Investment Management
Delaware
$504K -$8.16K -768 -2%
Alyeska Investment Group
31
Alyeska Investment Group
Illinois
$502K +$91.3K +8,590 +23%
ACM
32
Atika Capital Management
New York
$495K +$478K +45,000 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$442K -$113K -10,631 -21%
TCIM
34
TIAA CREF Investment Management
New York
$406K +$113K +10,680 +41%
ASP
35
Adams Street Partners
Illinois
$386K +$373K +35,073 New
EMG
36
Ellington Management Group
Connecticut
$307K +$297K +27,911 New
Charles Schwab
37
Charles Schwab
California
$303K +$14.1K +1,331 +5%
Goldman Sachs
38
Goldman Sachs
New York
$296K +$286K +26,881 New
GMIM
39
General Motors Investment Management
New York
$287K +$277K +26,023 New
TA
40
Teachers Advisors
New York
$213K – – –
PC
41
Polar Capital
United Kingdom
$209K -$34.3K -3,227 -15%
SO
42
STRS Ohio
Ohio
$208K +$181K +17,033 +896%
Prudential Financial
43
Prudential Financial
New Jersey
$208K +$201K +18,873 New
CS
44
Credit Suisse
Switzerland
$162K +$156K +14,670 New
GT
45
Glenmede Trust
Pennsylvania
$138K +$133K +12,546 New
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$133K +$7.44K +700 +6%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$120K +$6.33K +596 +6%
BCM
48
Bridgeway Capital Management
Texas
$111K – – –
KAS
49
Kemnay Advisory Services
New York
$107K +$103K +9,736 New
Morgan Stanley
50
Morgan Stanley
New York
$98K +$57.1K +5,377 +153%
1
2
3 4

VTAE Hedge Fund Activity: Q3 2015 in Review

70 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q3 2015, worth a combined $155M — down 19% from $193M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new VTAE positions and 7 closed out — a net gain of 17 holders — while 23 added to existing stakes and 15 trimmed.

The largest buyer was BVF Inc, adding an estimated $8.2M. The largest seller was NEA Management Company, exiting entirely with an estimated $37.6M sold.

  • 70 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q3 2015, up from 53 in Q2 2015.
  • Funds reported $155M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q3 2015, down 19% quarter-over-quarter.
  • 24 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q3 2015 and 7 closed out, a net change of +17 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q3 2015 was BVF Inc, an estimated $8.2M added.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q3 2015 was NEA Management Company, an estimated $37.6M sold.

Based on aggregated 13F filings for Q3 2015.